These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28604997)

  • 41. Prognostic Roles of SCC Antigen, CRP and CYFRA 21-1 in Oral Cavity Squamous Cell Carcinoma.
    DE Paz D; Young CK; Chien HT; Tsao CK; Fok CC; Fan KH; Liao CT; Wang HM; Kang CJ; Chang JT; Huang SF
    Anticancer Res; 2019 Apr; 39(4):2025-2033. PubMed ID: 30952746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyfra 21-1: a serological help for detection of distant metastases in head and neck cancer.
    Maass JD; Hoffmann-Fazel A; Goeroegh T; Hoffmann M; Meyer JE; Gottschlich S; Rudert H; Maune S
    Anticancer Res; 2000; 20(3B):2241-3. PubMed ID: 10928185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma.
    Washino S; Hirai M; Matsuzaki A; Kobayashi Y
    Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma.
    Shiiya H; Ujiie H; Hida Y; Kato T; Kaga K; Wakasa S; Kikuchi E; Shinagawa N; Okada K; Ito YM; Matsuno Y
    Thorac Cancer; 2021 Nov; 12(21):2933-2942. PubMed ID: 34581013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
    Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer.
    Boeck S; Wittwer C; Heinemann V; Haas M; Kern C; Stieber P; Nagel D; Holdenrieder S
    Br J Cancer; 2013 Apr; 108(8):1684-94. PubMed ID: 23579210
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease.
    Doweck I; Barak M; Uri N; Greenberg E
    Br J Cancer; 2000 Dec; 83(12):1696-701. PubMed ID: 11104568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.
    Kalfert D; Ludvik J; Kucera R; Topolcan O; Celakovsky P; Pesta M; Kholova I; Plzak J; Ludvikova M
    Anticancer Res; 2019 Sep; 39(9):5171-5177. PubMed ID: 31519630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cut-off value determination of CYFRA 21-1 for squamous cell carcinomas of the head and neck (SCCHN).
    Niemann AM; Goeroegh T; Gottschlich S; Lippert BM; Werner JA
    Anticancer Res; 1997; 17(4B):2859-60. PubMed ID: 9329547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
    Feng XY; Li JH; Li JZ; Han ZX; Xing RD
    Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of serum squamous cell carcinoma antigen and cytokeratin fragment antigen 21-1 for sinonasal inverted papilloma: an exploratory study.
    Zhang Z; Xu B; Wang L; Yan X; Li S; Jiang Y; Yu L
    Rhinology; 2024 Jun; 62(3):353-361. PubMed ID: 38189590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum.
    Patel JL; Erickson JA; Roberts WL; Grenache DG
    Clin Biochem; 2010 Dec; 43(18):1449-52. PubMed ID: 20875814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer.
    Gadducci A; Ferdeghini M; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
    Int J Gynecol Cancer; 2001; 11(4):277-82. PubMed ID: 11520365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
    Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
    Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study of Cyfra 21-1 as a new tumor marker for the diagnosis of epidermoid carcinoma of the head and neck].
    González Sánchez E; López-Ríos Velasco J; Calvo Boizas E; García-Talavera Fernández JR; Martín Ro-dríguez M; Muñoz Herrera A; Del Cañizo Alvarez A
    Acta Otorrinolaringol Esp; 1999 Mar; 50(2):85-9. PubMed ID: 10217679
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3.
    Haas M; Kern C; Kruger S; Michl M; Modest DP; Giessen C; Schulz C; von Einem JC; Ormanns S; Laubender RP; Holdenrieder S; Heinemann V; Boeck S
    Tumour Biol; 2015 Apr; 36(4):2631-40. PubMed ID: 25472579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYFRA 21-1 as a tumor marker for squamous cell carcinoma of the esophagus.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K; Watanabe S
    Dis Esophagus; 1998 Jan; 11(1):35-9. PubMed ID: 9595230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.